ArticleFrontiers in cellular and infection microbiology2025
Predicting tuberculosis progression in school contacts: novel host biomarkers for early risk assessment.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Combining ADA, IFN-γ, and IL-6 as host biomarkers enhances diagnosis of paucibacillary and extrapulmonary tuberculosis.Communications medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The low positive predictive value of tuberculin skin tests and interferon-γ release assays often results in unnecessary prophylaxis. This study aimed to identify antigen-specific biomarkers with high accuracy for predicting progression to active tuberculosis (ATB). QuantiFERON supernatants from a school tuberculosis outbreak cohort were analyzed, tracking students over two years to identify ATB cases. We assessed 67 cytokines using the Luminex Multiplex Array kit and applied LASSO and multivariate logistic regression to select predictors. A nomogram was developed from the coefficients of top predictors. Model performance was evaluated by AUC, C-index, and AIC. The levels of FGFbasic, GM-CSF, MPIF-1/CCL23, as well as the combinations of ratios of FGFbasic/GM-CSF and FGFbasic/MPIF-1/CCL23 were significantly associated with the risk of ATB. AUC values for the prediction models based on individual cytokines ranged from 0.607 to 0.713, notably lower than those of the fixed models based on the logistic regression (0.932) and LASSO regression (0.939). The LASSO regression model exhibited the best predictive performance, with a higher sensitivity (0.858 vs. 0.818) and specificity (0.949 vs.0.923), lower AIC (36.323 vs. 38.232), and equivalent C-index (0.939) compared to the traditional logistic regression model. The biomarkers identified in this study offer valuable insights for developing a more precise tool to identify individuals at high risk for rapid progression to ATB disease, enabling targeted interventions. The combination of multiple immune indicators shows significant promise in improving diagnostic accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.